Microvascular injuries, secondary edema, and inconsistencies in lung vascularization between affected and nonaffected pulmonary segments of non-critically ill hospitalized COVID-19 patients presenting with clinical deterioration

Cécile Maincent, Christophe Perrin, Gilles Chironi, Marie Baqué-Juston, Frédéric Berthier, Benoît Paulmier, Florent Hugonnet, Claire Dittlot, Ryan Lukas Farhad, Julien Renvoise, Benjamin Serrano, Valérie Nataf, François Mocquot, Olivia Keita-Perse, Yann-Erik Claessens, Marc Faraggi, Cécile Maincent, Christophe Perrin, Gilles Chironi, Marie Baqué-Juston, Frédéric Berthier, Benoît Paulmier, Florent Hugonnet, Claire Dittlot, Ryan Lukas Farhad, Julien Renvoise, Benjamin Serrano, Valérie Nataf, François Mocquot, Olivia Keita-Perse, Yann-Erik Claessens, Marc Faraggi

Abstract

Purpose: We aimed to better understand the pathophysiology of SARS-CoV-2 pneumonia in non-critically ill hospitalized patients secondarily presenting with clinical deterioration and increase in oxygen requirement without any identified worsening factors.

Methods: We consecutively enrolled patients without clinical or biological evidence for superinfection, without left ventricular dysfunction and for whom a pulmonary embolism was discarded by computed tomography (CT) pulmonary angiography. We investigated lung ventilation and perfusion (LVP) by LVP scintigraphy, and, 24 h later, left and right ventricular function by Tc-99m-labeled albumin-gated blood-pool scintigraphy with late (60 mn) tomographic albumin images on the lungs to evaluate lung albumin retention that could indicate microvascular injuries with secondary edema.

Results: We included 20 patients with confirmed SARS-CoV-2 pneumonia. All had CT evidence of organizing pneumonia and normal left ventricular ejection fraction. No patient demonstrated preserved ventilation with perfusion defect (mismatch), which may discard a distal lung thrombosis. Patterns of ventilation and perfusion were heterogeneous in seven patients (35%) with healthy lung segments presenting a relative paradoxical hypoperfusion and hypoventilation compared with segments with organizing pneumonia presenting a relative enhancement in perfusion and preserved ventilation. Lung albumin retention in area of organizing pneumonia was observed in 12 patients (60%), indicating microvascular injuries, increase in vessel permeability, and secondary edema.

Conclusion: In hospitalized non-critically ill patients without evidence of superinfection, pulmonary embolism, or cardiac dysfunction, various types of damage may contribute to clinical deterioration including microvascular injuries and secondary edema, inconsistencies in lung segments vascularization suggesting a dysregulation of the balance in perfusion between segments affected by COVID-19 and others.

Summary statement: Microvascular injuries and dysregulation of the balance in perfusion between segments affected by COVID-19 and others are present in non-critically ill patients without other known aggravating factors.

Key results: In non-critically ill patients without evidence of superinfection, pulmonary embolism, macroscopic distal thrombosis or cardiac dysfunction, various types of damage may contribute to clinical deterioration including 1/ microvascular injuries and secondary edema, 2/ inconsistencies in lung segments vascularization with hypervascularization of consolidated segments contrasting with hypoperfusion of not affected segments, suggesting a dysregulation of the balance in perfusion between segments affected by COVID-19 and others.

Trial registration: ClinicalTrials.gov NCT04990505.

Keywords: SARS-CoV-2 pneumonia; microvascular injury; pulmonary embolism; secondary edema; vasoconstriction; vasodilation.

Conflict of interest statement

Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Patients’ flow diagram. LVEF, left ventricular ejection fraction; SPECT, single photon emission computed tomography.
Figure 2.
Figure 2.
Patient no. 2. Perfusion (a), ventilation (b), and CT scan (c). Blue arrow: non-COVID-19-involved area of the right Fowler lobe, with paradoxically matched hypoperfusion and hypoventilation, while the COVID-19-involved area of the right superior lobe just in front remains perfused with a slightly hyperperfused peripheral halo (red arrow).
Figure 3.
Figure 3.
Patient no. 2. Albumin (a), CT (b), and fused CT + albumin scan (c). Green arrow: COVID-19 condensation of the right base with significant albumin uptake and moderate pleural effusion behind. There is also a moderate albumin uptake of the left inferior lobe. Albumin (d), CT (e), and fused CT + albumin scan (f). The moderate albumin uptake in the area of the peripheral halo of the COVID-19-involved area in the right superior lobe (red arrow) is related to the corresponding hyperperfusion displayed in Figure 2 (red arrow).
Figure 4.
Figure 4.
Patient no. 7. Axial (a) and coronal CT slices (b). Corresponding perfusion (d, e) and ventilation (g, h) scans. Corresponding coronal (c), axial (f), and saggital (i) fused albumin and CT scans. Green arrow: non-COVID-19-involved segment of the right inferior lobe, with paradoxically matched hypoperfusion and hypoventilation, while the COVID-19-involved area just behind (red arrow) is normally ventilated and perfused. (c), (f), (i): Red arrow: significant albumin uptake in several COVID-19-related condensed areas.

References

    1. Kory P, Kanne JP. SARS-CoV-2 organising pneumonia: ‘Has there been a widespread failure to identify and treat this prevalent condition in COVID-19? BMJ Open Respir Res 2020; 7: e000724.
    1. Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 2020; 202: 356–360.
    1. Roubinian NH, Dusendang JR, Mark DG, et al. Incidence of 30-day venous thromboembolism in adults tested for SARS-CoV-2 infection in an integrated health care system in Northern California. JAMA Intern Med 2021; 181: 997–1000.
    1. Jimenez D, Garcia-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis. Chest 2021; 159: 1182–1196.
    1. Afshar-Oromieh A, Prosch H, Schaefer-Prokop C, et al. A comprehensive review of imaging findings in COVID-19 – status in early 2021. Eur J Nucl Med Mol Imaging 2021; 48: 2500–2524.
    1. Sadegh Beigee F, Pourabdollah Toutkaboni M, Khalili N, et al. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients. Pathol Res Pract 2020; 216: 153228.
    1. Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020; 220: 1–13.
    1. Lang M, Som A, Mendoza DP, et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis 2020; 20: 1365–1366.
    1. Osuchowski MF, Winkler MS, Skirecki T, et al. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021; 9: 622–642.
    1. Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395: 1417–1418.
    1. Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020; 20: 1135–1140.
    1. Tian S, Hu W, Niu L, et al. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol 2020; 15: 700–704.
    1. Morris MF, Pershad Y, Kang P, et al. Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease. Eur Respir J 2021; 58: 2004133.
    1. George PM, Desai SR. COVID-19 pneumonia and the pulmonary vasculature – a marriage made in hell. Eur Respir J 2021; 58: 2100811.
    1. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: interim guidance, 2020, (accessed 15 June 2021).
    1. Maincent C, Berthier F, Fahrad RL, et al. Accuracy of routine biomarkers and blood leucocytes count to assist diagnosis of COVID-19-associated pneumonia in adult patients visiting the emergency department. Res Square 2021,
    1. Paez D, Gnanasegaran G, Fanti S, et al. COVID-19 pandemic: guidance for nuclear medicine departments. Eur J Nucl Med Mol Imaging 2020; 47: 1615–1619.
    1. Bajc M, Neilly JB, Miniati M, et al. EANM guidelines for ventilation/perfusion scintigraphy: part 1. Pulmonary imaging with ventilation/perfusion single photon emission tomography. Eur J Nucl Med Mol Imaging 2009; 36: 1356–1370.
    1. Bajc M, Neilly JB, Miniati M, et al. EANM guidelines for ventilation/perfusion scintigraphy: part 2. Algorithms and clinical considerations for diagnosis of pulmonary emboli with V/P(SPECT) and MDCT. Eur J Nucl Med Mol Imaging 2009; 36: 1528–1538.
    1. Bajc M, Chen Y, Wang J, et al. Identifying the heterogeneity of COPD by V/P SPECT: a new tool for improving the diagnosis of parenchymal defects and grading the severity of small airways disease. Int J Chron Obstruct Pulmon Dis 2017; 12: 1579–1587.
    1. Jogi J, Jonson B, Ekberg M, et al. Ventilation-perfusion SPECT with Tc-99m-DTPA versus Technegas: a head-to-head study in obstructive and nonobstructive disease. J Nucl Med 2010; 51: 735–741.
    1. Dhawan RT, Gopalan D, Howard L, et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir Med 2021; 9: 107–116.
    1. Cobes N, Guernou M, Lussato D, et al. Ventilation/perfusion SPECT/CT findings in different lung lesions associated with COVID-19: a case series. Eur J Nucl Med Mol Imaging 2020; 47: 2453–2460.
    1. Zuckier LS. To everything there is a season: taxonomy of approaches to the performance of lung scintigraphy in the era of COVID-19. Eur J Nucl Med Mol Imaging 2021; 48: 666–669.
    1. Bahloul A, Verger A, Mandry D, et al. Signs of tracheobronchitis may constitute the principal finding on the lung SPECT/CT images of COVID-19 patients. Eur J Nucl Med Mol Imaging 2021; 48: 2525–2530.
    1. Arce VM, Costoya JA. SARS-CoV-2 infection in K18-ACE2 transgenic mice replicates human pulmonary disease in COVID-19. Cell Mol Immunol 2021; 18: 513–514.
    1. Le Guludec D, Menad F, Faraggi M, et al. Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy. Chest 1994; 106: 1675–1682.
    1. Fu F, Lou J, Xi D, et al. Chest computed tomography findings of coronavirus disease 2019 (COVID-19) pneumonia. Eur Radiol 2020; 30: 5489–5498.
    1. Gurewich V, Thomas D, Stein M, et al. Bronchoconstriction in the presence of pulmonary embolism. Circulation 1963; 27: 339–345.
    1. Giuntini C. Ventilation/perfusion scan and dead space in pulmonary embolism: are they useful for the diagnosis. Q J Nucl Med 2001; 45: 281–286.
    1. Fernandes CJ, Luppino Assad A-P, Alves-Jr JA, et al. Pulmonary embolism and gas exchange. Respiration 2019; 98: 253–262.
    1. Lei Y, Zhang J, Schiavon CR, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res 2021; 128: 1323–1326.
    1. Herrero R, Sanchez G, Lorente JA. New insights into the mechanisms of pulmonary edema in acute lung injury. Ann Transl Med 2018; 6: 32.
    1. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120–128.

Source: PubMed

3
Subscribe